medigraphic.com

2016, Número 4

<< Anterior Siguiente >>

Rev Med Inst Mex Seguro Soc 2016; 54 (4)


Receptor de estrógenos alfa en obesidad y diabetes

Cahua-Pablo JÁ, Flores-Alfaro E, Cruz M

Idioma: Español
Referencias bibliográficas: 81
Paginas: 521-530
Archivo PDF: 218.29 Kb.


RESUMEN

El estradiol (E2) es una hormona importante en la fi siología reproductiva, cardiovascular, esquelética y en el sistema nervioso central (SNC). Tanto en humanos como en roedores, el E2 y sus receptores participan en el control del metabolismo energético y de la glucosa, tanto en salud como en enfermedades metabólicas. El receptor de estrógenos (RE) pertenece a una superfamilia de receptores nucleares (RN), los cuales son factores de transcripción que regulan la expresión génica. Existen tres RE: el RE-alfa, RE-beta y uno acoplado a la proteína GPER (GPR30), que en tejidos están involucrados en la homeostasis de glucosa y lípidos. También puede tener implicaciones importantes para factores de riesgo asociados al síndrome metabólico (SM), resistencia a la insulina (RI), obesidad y diabetes mellitus tipo 2 (DT2).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sukhanova A, Poly S, Shemetov A, Bronstein I, Nabiev I. Implications of protein structure instability: from physiological to pathological secondary structure. Biopolymers. 2012;97(8):577-88.

  2. Yki-Jarvinen H, Sahlin K, Ren JM, Koivisto VA. Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes. 1990;39(2):157-67.

  3. Thomas MP, Potter BV. The structural biology of oestrogen metabolism. J Steroid Biochem Mol Biol. 2013;137:27-49.

  4. Prossnitz ER, Oprea TI, Sklar LA, Arterburn JB. The ins and outs of GPR30: a transmembrane estrogen receptor. J Steroid Biochem Mol Biol. 2008;109(3-5): 350-3.

  5. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Med Pediatr Oncol. 2003;41 (3):217-21.

  6. Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A, et al. The role of estrogen in cardiovascular disease. J Surg Res. 2003;115(2):325-44.

  7. Toran-Allerand CD. Minireview: A plethora of estrogen receptors in the brain: where will it end? Endocrinology. 2004;145(3):1069-74.

  8. Kovacs EJ, Messingham KA, Gregory MS. Estrogen regulation of immune responses after injury. Mol Cell Endocrinol. 2002;193(1-2):129-35.

  9. Crespo CJ, Smit E, Snelling A, Sempos CT, An dersen RE. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care. 2002;25(10):1675-80.

  10. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice defi cient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A. 1998;95(12): 6965-70.

  11. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A. 2000;97(23):12729-34.

  12. Simpson ER, Misso M, Hewitt KN, Hill RA, Boon WC, Jones ME, et al. Estrogen--the good, the bad, and the unexpected. Endocr Rev. 2005;26(3):322-30.

  13. Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81(3):1269-304.

  14. Krishnan V, Heath H, Bryant HU. Mechanism of action of estrogens and selective estrogen receptor modulators. Vitam Horm. 2000;60:123-47.

  15. Nilsson M, Dahlman I, Ryden M, Nordstrom EA, Gustafsson JA, Arner P, et al. Oestrogen receptor alpha gene expression levels are reduced in obese compared to normal weight females. Int J Obes (Lond). 2007;31(6):900-7.

  16. Noriega-Reyes MY, McCarron L. Correguladores del Receptor de Estrógenos y su Implicación en el Cáncer Mamario. Cancerología. 2008;3:29-40.

  17. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001; 29(14):2905-19.

  18. Claessens F, Gewirth DT. DNA recognition by nuclear receptors. Essays Biochem. 2004;40:59-72.

  19. Kumar R, Johnson BH, Thompson EB. Overview of the structural basis for transcription regulation by nuclear hormone receptors. Essays Biochem. 2004;40:27-39.

  20. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801-11.

  21. Jiang M, Huhtaniemi I. Polymorphisms in androgen and estrogen receptor genes: effects on male aging. Exp Gerontol. 2004;39(11-12):1603-11.

  22. McEwan IJ. Sex, drugs and gene expression: signalling by members of the nuclear receptor superfamily. Essays Biochem. 2004;40:1-10.

  23. Orti E, Bodwell JE, Munck A. Phosphorylation of steroid hormone receptors. Endocr Rev. 1992;13(1): 105-28.

  24. Safe S, Kim K. Non-classical genomic estrogen receptor (ER)/specifi city protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol. 2008;41(5):263-75.

  25. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715):1625-30.

  26. Shang Y, Brown M. Molecular determinants for the tissue specifi city of SERMs. Science. 2002;295 (5564):2465-8.

  27. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116(3):561-70.

  28. Curtis SW, Washburn T, Sewall C, DiAugustine R, Lindzey J, Couse JF, et al. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen- like response to epidermal growth factor. Proc Natl Acad Sci U S A. 1996;93(22):12626-30.

  29. Le Goff P, Montano MM, Schodin DJ, Katzenellenbogen BS. Phosphorylation of the human estrogen receptor. Identifi cation of hormone-regulated sites and examination of their infl uence on transcriptional activity. J Biol Chem. 1994;269(6):4458-66.

  30. Thomas RS, Sarwar N, Phoenix F, Coombes RC, Ali S. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity. J Mol Endocrinol. 2008;40(4):173-84.

  31. Lannigan DA. Estrogen receptor phosphorylation. Steroids. 2003;68(1):1-9.

  32. Arnold SF, Melamed M, Vorojeikina DP, Notides AC, Sasson S. Estradiol-binding mechanism and binding capacity of the human estrogen receptor is regulated by tyrosine phosphorylation. Mol Endocrinol. 1997;11(1):48-53.

  33. Arnold SF, Vorojeikina DP, Notides AC. Phosphorylation of tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J Biol Chem. 1995;270(50):30205-12.

  34. Yang SH, Sarkar SN, Liu R, Perez EJ, Wang X, Wen Y, et al. Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem. 2009;284(14):9540-8.

  35. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, et al. 17 Beta-estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res. 1999;43(3):666-74.

  36. Hammes SR, Levin ER. Extranuclear steroid receptors: nature and actions. Endocr Rev. 2007;28(7): 726-41.

  37. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol- 3-OH kinase. Nature. 2000;407(6803):538-41.

  38. Xing D, Nozell S, Chen YF, Hage F, Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol. 2009;29(3):289-95.

  39. Bjorntorp P. Abdominal fat distribution and the metabolic syndrome. J Cardiovasc Pharmacol. 1992;20 Suppl 8:S26-8.

  40. Bouchard C, Despres JP, Mauriege P. Genetic and nongenetic determinants of regional fat distribution. Endocr Rev. 1993;14(1):72-93.

  41. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women’s Midlife Health Project. Climacteric. 2004; 7(4):375-89.

  42. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6 Suppl 1:60-75.

  43. Pedersen SB, Borglum JD, Moller-Pedersen T, Richelsen B. Effects of in vivo estrogen treatment on adipose tissue metabolism and nuclear estrogen receptor binding in isolated rat adipocytes. Mol Cell Endocrinol. 1992;85(1-2):13-9.

  44. Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav. 2009;97(2):199-204.

  45. Khaw KT, Barrett-Connor E. Lower endogenous androgens predict central adiposity in men. Ann Epidemiol. 1992;2(5):675-82.

  46. Moverare-Skrtic S, Venken K, Andersson N, Lindberg MK, Svensson J, Swanson C, et al. Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice. Obesity (Silver Spring). 2006;14(4):662-72.

  47. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443 (7109):289-95.

  48. Mitra SW, Hoskin E, Yudkovitz J, Pear L, Wilkinson HA, Hayashi S, et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology. 2003; 144(5):2055-67.

  49. Schlenker EH, Hansen SN. Sex-specifi c densities of estrogen receptors alpha and beta in the subnuclei of the nucleus tractus solitarius, hypoglossal nucleus and dorsal vagal motor nucleus weanling rats. Brain Res. 2006;1123(1):89-100.

  50. Moran TH. Gut peptides in the control of food intake. Int J Obes (Lond). 2009;33 Suppl 1:S7-10.

  51. Butera PC, Bradway DM, Cataldo NJ. Modulation of the satiety effect of cholecystokinin by estradiol. Physiol Behav. 1993;53(6):1235-8.

  52. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013;34(3):309-38.

  53. Cooke PS, Heine PA, Taylor JA, Lubahn DB. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol. 2001;178(1-2):147-54.

  54. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008; 73(9-10):874-9.

  55. Bailey CJ, Ahmed-Sorour H. Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. Diabetologia. 1980;19(5):475-81.

  56. Alonso-Magdalena P, Ropero AB, Carrera MP, Cederroth CR, Baquie M, Gauthier BR, et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One. 2008;3(4):e2069.

  57. Zhu L, Brown WC, Cai Q, Krust A, Chambon P, Mc- Guinness OP, et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes. 2013;62(2):424-34.

  58. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, et al. Estrogens protect pancreatic betacells from apoptosis and prevent insulin-defi cient diabetes mellitus in mice. Proc Natl Acad Sci U S A. 2006;103(24):9232-7.

  59. Vogel H, Mirhashemi F, Liehl B, Taugner F, Kluth O, Kluge R, et al. Estrogen defi ciency aggravates insulin resistance and induces beta-cell loss and diabetes in female New Zealand obese mice. Horm Metab Res. 2013;45(6):430-5.

  60. Meyer MR, Haas E, Prossnitz ER, Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. 2009;308(1-2):9-16.

  61. Meyer MR, Haas E, Prossnitz ER, Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. 2009;308(1-2):9-16. 61. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21(6):697-738. 62 Schneider G, Kirschner MA, Berkowitz R, Ertel NH. Increased estrogen production in obese men. J Clin Endocrinol Metab. 1979;48(4):633-8.

  62. Tchernof A, Després J-P, Dupont A, Bélanger A, Nadeau A, Prud’homme D, et al. Relation of Steroid Hormones to Glucose Tolerance and Plasma Insulin Levels in Men: Importance of visceral adipose tissue. Diabetes Care. 1995;18(3):292-9.

  63. Mizutani T, Nishikawa Y, Adachi H, Enomoto T, Ikegami H, Kurachi H, et al. Identifi cation of estrogen receptor in human adipose tissue and adipocytes. J Clin Endocrinol Metab. 1994;78(4):950-4.

  64. Price TM, O’Brien SN. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplifi cation. J Clin Endocrinol Metab. 1993;77(4):1041-5.

  65. Dieudonne MN, Leneveu MC, Giudicelli Y, Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specifi cities and regulation by estrogens. Am J Physiol Cell Physiol. 2004;286(3):C655-61.

  66. Ogawa S, Chan J, Chester AE, Gustafsson JA, Korach KS, Pfaff DW. Survival of reproductive behaviors in estrogen receptor beta gene-defi cient (betaERKO) male and female mice. Proc Natl Acad Sci U S A. 1999;96(22):12887-92.

  67. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(16):1056-61.

  68. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms in the estrogen receptor alpha gene with body fat distribution. Int J Obes Relat Metab Disord. 2003;27(9):1020-7.

  69. Casazza K, Page GP, Fernandez JR. The association between the rs2234693 and rs9340799 estrogen receptor alpha gene polymorphisms and risk factors for cardiovascular disease: a review. Biol Res Nurs. 2010;12(1):84-97.

  70. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, et al. Impaired oxidative metabolism and infl ammation are associated with insulin resistance in ERalpha-defi cient mice. Am J Physiol Endocrinol Metab. 2010;298(2):E304-19.

  71. Deng HW, Li J, Li JL, Dowd R, Davies KM, Johnson M, et al. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J Clin Endocrinol Metab. 2000;85(8):2748-51.

  72. Bjornholm M, Zierath JR. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. Biochem Soc Trans. 2005;33(Pt 2): 354-7.

  73. Barros RP, Gabbi C, Morani A, Warner M, Gustafsson JA. Participation of ER-alpha and ER-beta in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 2009;297(1):E124-33.

  74. 75 Barros RP, Gustafsson JA. Estrogen receptors and the metabolic network. Cell Metab. 2011;14(3): 289-99.

  75. Zhou L, Chen H, Xu P, Cong LN, Sciacchitano S, Li Y, et al. Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells. Mol Endocrinol. 1999;13(3):505-14.

  76. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond). 2002;102(2):151-66.

  77. Rogers NH, Witczak CA, Hirshman MF, Goodyear LJ, Greenberg AS. Estradiol stimulates Akt, AMPactivated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus. Biochem Biophys Res Commun. 2009;382(4):646-50.

  78. Moreno M, Ordonez P, Alonso A, Diaz F, Tolivia J, Gonzalez C. Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging. Age (Dordr). 2010;32(1):1-13.

  79. Alexanderson C, Eriksson E, Stener-Victorin E, Lonn M, Holmang A. Early postnatal oestradiol exposure causes insulin resistance and signs of infl ammation in circulation and skeletal muscle. J Endocrinol. 2009;201(1):49-58.

  80. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, et al. Evidence that oestrogen receptor- alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia. 2006;49(3):588-97.

  81. Barros RP, Machado UF, Warner M, Gustafsson JA. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci U S A. 2006; 103(5):1605-8.




2020     |     www.medigraphic.com